MENU
SMRI
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Mid-Cap Value
Interact to see
Advertisement
A.I.Advisor
published price charts
SMRI
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for SMRI with price predictions
Oct 22, 2026

Momentum Indicator for SMRI turns positive, indicating new upward trend

SMRI saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator turned positive. In 43 of the 46 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SMRI just turned positive on October 08, 2026. Looking at past instances where SMRI's MACD turned positive, the stock continued to rise in 28 of 32 cases over the following month. The odds of a continued upward trend are 88%.

SMRI moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SMRI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

Following a +1.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMRI advanced for three days, in 180 of 212 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

SMRI broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SMRI entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Micron Technology (NASDAQ:MU), ExxonMobil Holdings Corporation (NYSE:XOM), Netflix Inc. (NASDAQ:NFLX), International Business Machines Corp (NYSE:IBM), Salesforce (NYSE:CRM), QUALCOMM (NASDAQ:QCOM), ConocoPhillips (NYSE:COP), Accenture PLC (NYSE:ACN), Uber Technologies (NYSE:UBER).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF (SMRI) ETF is 101.42B. The market cap for tickers in the group ranges from 11.7B to 1.13T. LLY holds the highest valuation in this group at 1.13T. The lowest valued company is BWA at 11.7B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF (SMRI) ETF was 1%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was 30%. ACN experienced the highest price growth at 15%, while CDE experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF (SMRI) ETF was 8%. For the same stocks of the ETF, the average monthly volume growth was -2% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 72
P/E Growth Rating: 47
Price Growth Rating: 37
SMR Rating: 49
Profit Risk Rating: 52
Seasonality Score: 33 (-100 ... +100)
Momentum Indicator for SMRI turns positive, indicating new upward trend